ロード中...
Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer – A Case Report
Solid tumors harboring BRCA1 or BRCA2 mutations have been shown to respond to PARP inhibitors. These responses are partial and transient. In this case report, we describe an 82-year-old male with poorly differentiated prostate cancer with metastases to the lung, liver, abdomen, and bowel. Molecular...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4510409/ https://ncbi.nlm.nih.gov/pubmed/26258074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2015.00169 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|